Weekend reads: A celebrity surgeon’s double life; misconduct in sports medicine; researcher loses honor

booksThis week at Retraction Watch featured a literally bullshit excuse for fake data, a new record for time from publication to retraction, and news of an upcoming retraction from Science. Here’s what was happening elsewhere: Continue reading Weekend reads: A celebrity surgeon’s double life; misconduct in sports medicine; researcher loses honor

Weekend reads: Why authors keep citing retracted studies; patients over papers; final ruling in Hwang case

booksHere’s our first post of 2016. The week at Retraction Watch featured a retraction from JAMA, and our list of most-cited retracted papers. Here’s what was happening elsewhere: Continue reading Weekend reads: Why authors keep citing retracted studies; patients over papers; final ruling in Hwang case

Weekend reads: NFL, NIH butt heads on concussion research; should all papers be anonymous?

booksThe week at Retraction Watch featured our annual roundup of the year’s top retractions for The Scientist, a retraction from Science, and claims about a book Aristotle never wrote. Here’s what was happening elsewhere: Continue reading Weekend reads: NFL, NIH butt heads on concussion research; should all papers be anonymous?

Weekend reads: 179 researchers indicted; how to reject a rejection; breaking the law on clinical trial data

booksThe week at Retraction Watch featured more installments in the seemingly never-ending story of fake peer reviews. Here’s what was happening elsewhere: Continue reading Weekend reads: 179 researchers indicted; how to reject a rejection; breaking the law on clinical trial data

Weekend reads: What do PhDs earn?; university refuses to release data; collaboration’s dark side

booksThis week at Retraction Watch featured a look at the huge problem of misidentified cell lines, a check-in with a company that retracted a paper as it was about to go public, and Diederik Stapel’s 58th retraction. Here’s what was happening elsewhere: Continue reading Weekend reads: What do PhDs earn?; university refuses to release data; collaboration’s dark side

Weekend reads: Retraction reluctance; worthless papers (and stats); too many PhDs

booksThe week at Retraction Watch featured a new grant to our parent non-profit organization, a retraction from the NEJM, and our first-ever retraction. Here’s what was happening elsewhere: Continue reading Weekend reads: Retraction reluctance; worthless papers (and stats); too many PhDs

Weekend reads: Criminal charges for plagiarism; NFL scientific interference; the authorship explosion

booksThe week at Retraction Watch featured a move by the Journal of Biological Chemistry that we’re applauding, a retraction by a high-profile nutrition researcher, and an announcement about a new partnership to create a retraction database. Here’s what was happening elsewhere: Continue reading Weekend reads: Criminal charges for plagiarism; NFL scientific interference; the authorship explosion

Weekend reads: Papers de-emphasized for funding; reproducibility revolution; reining in fraud in China

booksThe week at Retraction Watch featured a particularly misleading retraction notice, and a university stripping a graduate of her PhD for misconduct. Here’s what was happening elsewhere: Continue reading Weekend reads: Papers de-emphasized for funding; reproducibility revolution; reining in fraud in China

Weekend reads: The end of journals?; Impact Factor for sale; fake peer reviews earn funding bans

booksThis morning, our thoughts are with the people of Paris. The week at Retraction Watch featured the retraction of a paper claiming dramatically higher rates of sexual trauma among men in the military, and a look at whether gender plays a role in peer review. Also: We’re hiring. Here’s what was happening elsewhere: Continue reading Weekend reads: The end of journals?; Impact Factor for sale; fake peer reviews earn funding bans

Weekend reads: Elsevier mutiny; babies as co-authors; what to do after rejection

booksThis week’s Weekend Reads, which appears below, was preempted yesterday by the news that the Office of Research Integrity had issued a finding of misconduct in the long-running case of Anil Potti. The week also featured news about a child psychiatry trial halted for unexplained reasons, and saw the launch of our new weekly column at STAT, a new life sciences site from Boston Globe Media. Here’s what was happening elsewhere: Continue reading Weekend reads: Elsevier mutiny; babies as co-authors; what to do after rejection